Search
 

Valeant CEO agrees to testify to Congress

Michael Pearson has agreed to testify to Congress about the companys pricing strategy.

By Jack Craver | Updated on April 14, 2016
Photo: Getty Images

The CEO of Valeant, a Canadian pharmaceutical company at the center of an ongoing inquiry into price gouging in the drug industry, has agreed to testify to Congress about the company’s pricing strategy.

The agreement by Michael Pearson to explain some of the company’s controversial business practices comes after months of bad news for the company. In addition to being lambasted for jacking up the prices of many drugs that it bought the rights to, Valeant has been accused of prematurely reporting sales to Philidor, the mail-order pharmacy.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Jack Craver

Recommended Stories

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2024 ALM Global, LLC. All Rights Reserved.